IL-12 promotes the differentiation of naïve CD8+ T cells to the effector phenotype and acts as a CD8+ T-anti-apoptotic factor that can directly destroy microorganisms and cancer cells through the release of perforin and proteolytic enzymes [362,363]. This evidence concerns the gene CD8A and cancer.